The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Caveolin-1 Null Mice Are Viable but Show Evidence of Hyperproliferative and Vascular Abnormalities
Open accessAbstract
Caveolin-1 is the principal structural protein of caveolae membranes in fibroblasts and endothelia. Recently, we have shown that the human CAV-1 gene is localized to a suspected tumor suppressor locus, and mutations in Cav-1 have been implicated in human cancer. Here, we created a caveolin-1 null (CAV-1 -/-) mouse model, using standard homologous recombination techniques, to assess the role of caveolin-1 in caveolae biogenesis, endocytosis, cell proliferation, and endothelial nitric-oxide synthase (eNOS) signaling. Surprisingly, Cav-1 null mice are viable. We show that these mice lack caveolin-1 protein expression and plasmalemmal caveolae. In addition, analysis of cultured fibroblasts from Cav-1 null embryos reveals the following: (i) a loss of caveolin-2 protein expression; (ii) defects in the endocytosis of a known caveolar ligand, i.e. fluorescein isothiocyanate-albumin; and (iii) a hyperproliferative phenotype. Importantly, these phenotypic changes are reversed by recombinant expression of the caveolin-1 cDNA. Furthermore, examination of the lung parenchyma (an endothelial-rich tissue) shows hypercellularity with thickened alveolar septa and an increase in the number of vascular endothelial growth factor receptor (Flk-1)-positive endothelial cells. As predicted, endothelial cells from Cav-1 null mice lack caveolae membranes. Finally, we examined eNOS signaling by measuring the physiological response of aortic rings to various stimuli. Our results indicate that eNOS activity is up-regulated in Cav-1 null animals, and this activity can be blunted by using a specific NOS inhibitor, nitro-l-arginine methyl ester. These findings are in accordance with previous in vitro studies showing that caveolin-1 is an endogenous inhibitor of eNOS. Thus, caveolin-1 expression is required to stabilize the caveolin-2 protein product, to mediate the caveolar endocytosis of specific ligands, to negatively regulate the proliferation of certain cell types, and to provide tonic inhibition of eNOS activity in endothelial cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
JUNCTIONAL COMPLEXES IN VARIOUS EPITHELIA
Farquhar, M. G., & Palade, G. E. (1963) · The Journal of Cell Biology · doi:10.1083/jcb.17.2.375 · Cited by 3,635
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
Caveolin, a protein component of caveolae membrane coats
Rothberg, K. G., Heuser, J. E., Donzell, W. C., Ying, Y.-S., Glenney, J. R., & Anderson, R. G. W. (1992) · Cell · doi:10.1016/0092-8674(92)90143-z · Cited by 2,258
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice
Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F. C., et al. (2001) · Science · doi:10.1126/science.1062688 · Cited by 1,552
Research works printed but not linked: 18
- Li, 1996, J. Biol. Chem., 271, 28647, 10.1074/jbc.271.45.28647 · doi:10.1074/jbc.271.45.28647
- Song, 1997, Cell. Mol. Biol., 43, 293
- Razani, 2000, Biochemistry, 39, 13916, 10.1021/bi001489b · doi:10.1021/bi001489b
- Park, 2001, Biochemistry, 40, 3354, 10.1021/bi002787b · doi:10.1021/bi002787b
- Bender, 2000, Cancer Res., 60, 5870
- Bagnoli, 2000, Oncogene, 19, 4754, 10.1038/sj.onc.1203839 · doi:10.1038/sj.onc.1203839
- Engelman, 1999, FEBS Lett., 448, 221, 10.1016/S0014-5793(99)00365-8 · doi:10.1016/s0014-5793(99)00365-8
- Suzuki, 1998, J. Biochem. (Tokyo), 124, 383, 10.1093/oxfordjournals.jbchem.a022123 · doi:10.1093/oxfordjournals.jbchem.a022123
- Jenkins, 1998, Cancer Res., 58, 759
- Zenklusen, 1994, Cancer Res., 54, 6370
- Zenklusen, 1994, Proc. Natl. Acad. Sci. U. S. A., 91, 12155, 10.1073/pnas.91.25.12155 · doi:10.1073/pnas.91.25.12155
- Zenklusen, 1995, Cancer Res., 55, 1347
- Zenklusen, 1995, Oncogene, 11, 359
- Achille, 1996, Cancer Res., 56, 3808
- Hayashi, 2001, Cancer Res., 61, 2361
- Das, 1999, J. Biol. Chem., 274, 18721, 10.1074/jbc.274.26.18721 · doi:10.1074/jbc.274.26.18721
- Gerdes, 1991, Am. J. Pathol., 138, 867
- Drab, 2001, Science
Cited by
Routes and mechanisms of extracellular vesicle uptake
Mulcahy, L. A., Pink, R. C., & Carter, D. R. F. (2014) · Journal of Extracellular Vesicles · doi:10.3402/jev.v3.24641 · Cited by 2,832
“CAV1 null mice show phenotypic changes in vasculature but are viable (106), suggesting that either CAV1 is not essential for full EV uptake or that the ability to internalize vesicles via CDE is not essential for viability.”
BackgroundSignaling Mechanisms Regulating Endothelial Permeability
Mehta, D., & Malik, A. B. (2006) · Physiological Reviews · doi:10.1152/physrev.00012.2005 · Cited by 1,720
The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
Pavlides, S., Whitaker-Menezes, D., Castello-Cros, R., Flomenberg, N., Witkiewicz, A. K., Frank, P. G., Casimiro, M. C., Wang, C., Fortina, P., Addya, S., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.23.10238 · Cited by 1,391
Self-citationSystemic sclerosis: a prototypic multisystem fibrotic disorder
Varga, J., & Abraham, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31139 · Cited by 1,163
Caveolae: From Cell Biology to Animal Physiology
Razani, B., Woodman, S. E., & Lisanti, M. P. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.431 · Cited by 987
Self-citationMolecular mechanisms involved in the regulation of the endothelial nitric oxide synthase
Fleming, I., & Busse, R. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00323.2002 · Cited by 940
Role of Caveolae and Caveolins in Health and Disease
Cohen, A. W., Hnasko, R., Schubert, W., & Lisanti, M. P. (2004) · Physiological Reviews · doi:10.1152/physrev.00046.2003 · Cited by 893
Self-citationCaveolae/raft-dependent endocytosis
Nabi, I. R., & Le, P. U. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302028 · Cited by 749
Pelkmans, L., & Helenius, A. (2002) · Traffic · doi:10.1034/j.1600-0854.2002.30501.x · Cited by 747
Klaassen, I., Van Noorden, C. J. F., & Schlingemann, R. O. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.02.001 · Cited by 722
Goetz, J. G., Minguet, S., Navarro-Lérida, I., Lazcano, J. J., Samaniego, R., Calvo, E., Tello, M., Osteso-Ibáñez, T., Pellinen, T., Echarri, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.05.040 · Cited by 720
Knowland, D., Arac, A., Sekiguchi, K. J., Hsu, M., Lutz, S. E., Perrino, J., Steinberg, G. K., Barres, B. A., Nimmerjahn, A., & Agalliu, D. (2014) · Neuron · doi:10.1016/j.neuron.2014.03.003 · Cited by 703
“P A A uthor M anuscript vessels at 27 h, in either wild-type or Cav1-deficient mice that lack EC caveolae (Drab et al., 2001; Razani et al., 2001).”
Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2
Parmar, K. M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24787 · Cited by 701
Brutsaert, D. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00017.2002 · Cited by 697
Transcytosis: Crossing Cellular Barriers
TUMA, P. L., & HUBBARD, A. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00001.2003 · Cited by 681
Lu, Z., Ghosh, S., Wang, Z., & Hunter, T. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00304-0 · Cited by 647
Regulation of Endothelial Permeability via Paracellular and Transcellular Transport Pathways
Komarova, Y., & Malik, A. B. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135833 · Cited by 641
Andreone, B. J., Chow, B. W., Tata, A., Lacoste, B., Ben-Zvi, A., Bullock, K., Deik, A. A., Ginty, D. D., Clish, C. B., & Gu, C. (2017) · Neuron · doi:10.1016/j.neuron.2017.03.043 · Cited by 636
Lipid Rafts and Caveolae as Portals for Endocytosis: New Insights and Common Mechanisms
Parton, R. G., & Richards, A. A. (2003) · Traffic · doi:10.1034/j.1600-0854.2003.00128.x · Cited by 603
Autophagy Links Inflammasomes to Atherosclerotic Progression
Razani, B., Feng, C., Coleman, T., Emanuel, R., Wen, H., Hwang, S., Ting, J. P., Virgin, H. W., Kastan, M. B., & Semenkovich, C. F. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.02.011 · Cited by 601
Self-citationEndocytosis unplugged: Multiple ways to enter the cell
Kumari, S., MG, S., & Mayor, S. (2010) · Cell Research · doi:10.1038/cr.2010.19 · Cited by 599
Multiple Functions of Caveolin-1
Liu, P., Rudick, M., & Anderson, R. G. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200020200 · Cited by 591
Razani, B., Combs, T. P., Wang, X. B., Frank, P. G., Park, D. S., Russell, R. G., Li, M., Tang, B., Jelicks, L. A., Scherer, P. E., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110970200 · Cited by 583
Self-citationBonuccelli, G., Tsirigos, A., Whitaker-Menezes, D., Pavlides, S., Pestell, R. G., Chiavarina, B., Frank, P. G., Flomenberg, N., Howell, A., Martinez-Outschoorn, U. E., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.17.12731 · Cited by 576
Self-citationEmerging Themes in Lipid Rafts and Caveolae
Galbiati, F., Razani, B., & Lisanti, M. P. (2001) · Cell · doi:10.1016/s0092-8674(01)00472-x · Cited by 567
Self-citationFree radical biology and medicine
(2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00484-2 · Cited by 549
Caveolin-1 in oncogenic transformation, cancer, and metastasis
Williams, T. M., & Lisanti, M. P. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00458.2004 · Cited by 511
Self-citationFulton, D., Gratton, J.-P., & Sessa, W. C. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29198-9 · Cited by 495
Estrogen and the cardiovascular system
Knowlton, A. A., & Lee, A. R. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.03.007 · Cited by 489
Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells
Münch, C., O’Brien, J., & Bertolotti, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017275108 · Cited by 479
Marchiando, A. M., Shen, L., Graham, W. V., Weber, C. R., Schwarz, B. T., Austin, J. R., Raleigh, D. R., Guan, Y., Watson, A. J. M., Montrose, M. H., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200902153 · Cited by 477
Balligand, J.-L., Feron, O., & Dessy, C. (2009) · Physiological Reviews · doi:10.1152/physrev.00042.2007 · Cited by 477
Regulation of TFEB and V-ATPases by mTORC1
Peña-Llopis, S., Vega-Rubin-de-Celis, S., Schwartz, J. C., Wolff, N. C., Tran, T. A. T., Zou, L., Xie, X.-J., Corey, D. R., & Brugarolas, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.257 · Cited by 462
Martinez-Outschoorn, U. E., Balliet, R. M., Rivadeneira, D., Chiavarina, B., Pavlides, S., Wang, C., Whitaker-Menezes, D., Daumer, K., Lin, Z., Witkiewicz, A., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.16.12553 · Cited by 460
Self-citationUltrastructural identification of uncoated caveolin-independent early endocytic vehicles
Kirkham, M., Fujita, A., Chadda, R., Nixon, S. J., Kurzchalia, T. V., Sharma, D. K., Pagano, R. E., Hancock, J. F., Mayor, S., & Parton, R. G. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200407078 · Cited by 439
Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice
Zhao, Y.-Y., Liu, Y., Stan, R.-V., Fan, L., Gu, Y., Dalton, N., Chu, P.-H., Peterson, K., Ross, J., & Chien, K. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172360799 · Cited by 448
Caveolae as Organizers of Pharmacologically Relevant Signal Transduction Molecules
Patel, H. H., Murray, F., & Insel, P. A. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.121506.124841 · Cited by 439
Molecular mechanisms underlying the activation of eNOS
Fleming, I. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0767-7 · Cited by 437
Regulation of Amino Acid and Glucose Transporters in Endothelial and Smooth Muscle Cells
Mann, G. E., Yudilevich, D. L., & Sobrevia, L. (2003) · Physiological Reviews · doi:10.1152/physrev.00022.2002 · Cited by 430
Role of Krüppel-Like Transcription Factors in Endothelial Biology
Atkins, G. B., & Jain, M. K. (2007) · Circulation Research · doi:10.1161/01.res.0000267856.00713.0a · Cited by 419
Nitric Oxide and the Vascular Endothelium
Moncada, S., & Higgs, E. A. (2006) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-32967-6_7 · Cited by 408
Angiogenesis in the atherosclerotic plaque
Camaré, C., Pucelle, M., Nègre-Salvayre, A., & Salvayre, R. (2017) · Redox Biology · doi:10.1016/j.redox.2017.01.007 · Cited by 401
Caveosomes and endocytosis of lipid rafts
Nichols, B. (2003) · Journal of Cell Science · doi:10.1242/jcs.00840 · Cited by 389
Caveolin, Caveolae, and Endothelial Cell Function
Frank, P. G., Woodman, S. E., Park, D. S., & Lisanti, M. P. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000070546.16946.3a · Cited by 384
Self-citationYu, J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27100 · Cited by 383
Molecular mechanisms of endothelial hyperpermeability: implications in inflammation
Kumar, P., Shen, Q., Pivetti, C. D., Lee, E. S., Wu, M. H., & Yuan, S. Y. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001112 · Cited by 380
Phospho-caveolin-1 mediates integrin-regulated membrane domain internalization
del Pozo, M. A., Balasubramanian, N., Alderson, N. B., Kiosses, W. B., Grande-García, A., Anderson, R. G. W., & Schwartz, M. A. (2005) · Nature Cell Biology · doi:10.1038/ncb1293 · Cited by 379
Austin, E. D., Ma, L., LeDuc, C., Berman Rosenzweig, E., Borczuk, A., Phillips, J. A., Palomero, T., Sumazin, P., Kim, H. R., Talati, M. H., et al. (2012) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.111.961888 · Cited by 378
The Caveolin genes: from cell biology to medicine
Williams, T. M., & Lisanti, M. P. (2004) · Annals of Medicine · doi:10.1080/07853890410018899 · Cited by 369
Self-citationExploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis
Sergin, I., Evans, T. D., Zhang, X., Bhattacharya, S., Stokes, C. J., Song, E., Ali, S., Dehestani, B., Holloway, K. B., Micevych, P. S., et al. (2017) · Nature Communications · doi:10.1038/ncomms15750 · Cited by 351
Self-citationEndocytosis and signaling: Cell logistics shape the eukaryotic cell plan
Sigismund, S., Confalonieri, S., Ciliberto, A., Polo, S., Scita, G., & Di Fiore, P. P. (2012) · Physiological Reviews · doi:10.1152/physrev.00005.2011 · Cited by 338
“The interaction of eNOS with caveolin-1 inhibits the function of eNOS (90, 250), as also supported by findings in caveolin-1-deficient mice that display increased nitric oxide production (642).”
Cohen, A. W., Razani, B., Wang, X. B., Combs, T. P., Williams, T. M., Scherer, P. E., & Lisanti, M. P. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00006.2003 · Cited by 351
Self-citationCaveolin-1 regulates cell polarization and directional migration through Src kinase and Rho GTPases
Grande-García, A., Echarri, A., de Rooij, J., Alderson, N. B., Waterman-Storer, C. M., Valdivielso, J. M., & del Pozo, M. A. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200701006 · Cited by 341
Caveolae-deficient Endothelial Cells Show Defects in the Uptake and Transport of Albumin in Vivo
Schubert, W., Frank, P. G., Razani, B., Park, D. S., Chow, C.-W., & Lisanti, M. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100613200 · Cited by 337
Self-citationNeurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation
Corrigan, F., Mander, K. A., Leonard, A. V., & Vink, R. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0738-9 · Cited by 331
Pulmonary Hypertension in Heart Failure
Guazzi, M., & Naeije, R. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.01.051 · Cited by 329
Tumor-Suppressor Functions of the TP53 Pathway
Aubrey, B. J., Strasser, A., & Kelly, G. L. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026062 · Cited by 327
Razani, B., Wang, X. B., Engelman, J. A., Battista, M., Lagaud, G., Zhang, X. L., Kneitz, B., Hou, H., Christ, G. J., Edelmann, W., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2329-2344.2002 · Cited by 320
Self-citationMicrovascular Hyperpermeability in Caveolin-1 (−/−) Knock-out Mice
Schubert, W., Frank, P. G., Woodman, S. E., Hyogo, H., Cohen, D. E., Chow, C.-W., & Lisanti, M. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205948200 · Cited by 319
Self-citationRole of Caveolin-1 in the Modulation of Lipolysis and Lipid Droplet Formation
Cohen, A. W., Razani, B., Schubert, W., Williams, T. M., Wang, X. B., Iyengar, P., Brasaemle, D. L., Scherer, P. E., & Lisanti, M. P. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1261 · Cited by 319
Self-citationCaveolae and Caveolins in the Cardiovascular System
Gratton, J.-P., Bernatchez, P., & Sessa, W. C. (2004) · Circulation Research · doi:10.1161/01.res.0000129178.56294.17 · Cited by 317
The inner blood-retinal barrier: Cellular basis and development
Díaz-Coránguez, M., Ramos, C., & Antonetti, D. A. (2017) · Vision Research · doi:10.1016/j.visres.2017.05.009 · Cited by 314
Genetic Defects in Ciliary Structure and Function
Zariwala, M. A., Knowles, M. R., & Omran, H. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.040705.141301 · Cited by 312
Dissecting lipid raft facilitated cell signaling pathways in cancer
Patra, S. K. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.11.002 · Cited by 311
Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation
Chidlow, J. H., & Sessa, W. C. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq075 · Cited by 310
Lipid rafts as major platforms for signaling regulation in cancer
Mollinedo, F., & Gajate, C. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.10.003 · Cited by 308
Kone, B. C., Kuncewicz, T., Zhang, W., & Yu, Z.-Y. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00048.2003 · Cited by 305
Lipid rafts in health and disease
Michel, V., & Bakovic, M. (2007) · Biology of the Cell · doi:10.1042/bc20060051 · Cited by 304
Caveolin regulation of endothelial function
Minshall, R. D., Sessa, W. C., Stan, R. V., Anderson, R. G. W., & Malik, A. B. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00242.2003 · Cited by 302
Oh, P., Borgström, P., Witkiewicz, H., Li, Y., Borgström, B. J., Chrastina, A., Iwata, K., Zinn, K. R., Baldwin, R., Testa, J. E., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1292 · Cited by 300
Caveolin-1 in tumor progression: the good, the bad and the ugly
Goetz, J. G., Lajoie, P., Wiseman, S. M., & Nabi, I. R. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9160-9 · Cited by 299
Caveolin-1 is ubiquitinated and targeted to intralumenal vesicles in endolysosomes for degradation
Hayer, A., Stoeber, M., Ritz, D., Engel, S., Meyer, H. H., & Helenius, A. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201003086 · Cited by 298
Maxfield, F. R. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00351-4 · Cited by 296
Caveolae: anchored, multifunctional platforms in the lipid ocean
Deurs, B. V., Roepstorff, K., Hommelgaard, A. M., & Sandvig, K. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(02)00039-9 · Cited by 296
Transcytosis at the blood–brain barrier
Ayloo, S., & Gu, C. (2019) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2018.12.014 · Cited by 296
Exploring the caves: cavins, caveolins and caveolae
Hansen, C. G., & Nichols, B. J. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.005 · Cited by 295
Signal transduction by protease‐activated receptors
Soh, U. J., Dores, M. R., Chen, B., & Trejo, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00705.x · Cited by 294
Pavlides, S., Vera, I., Gandara, R., Sneddon, S., Pestell, R. G., Mercier, I., Martinez-Outschoorn, U. E., Whitaker-Menezes, D., Howell, A., Sotgia, F., et al. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4243 · Cited by 289
Self-citationPassing the Vascular Barrier: Endothelial Signaling Processes Controlling Extravasation
Wettschureck, N., Strilic, B., & Offermanns, S. (2019) · Physiological Reviews · doi:10.1152/physrev.00037.2018 · Cited by 286
Molecular mechanisms of clathrin-independent endocytosis
Hansen, C. G., & Nichols, B. J. (2009) · Journal of Cell Science · doi:10.1242/jcs.033951 · Cited by 285
Witkiewicz, A. K., Dasgupta, A., Sotgia, F., Mercier, I., Pestell, R. G., Sabel, M., Kleer, C. G., Brody, J. R., & Lisanti, M. P. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080873 · Cited by 283
Self-citationCaveolin-1 and Cancer Metabolism in the Tumor Microenvironment: Markers, Models, and Mechanisms
Sotgia, F., Martinez-Outschoorn, U. E., Howell, A., Pestell, R. G., Pavlides, S., & Lisanti, M. P. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-120856 · Cited by 281
Self-citationWilliams, T. M., Medina, F., Badano, I., Hazan, R. B., Hutchinson, J., Muller, W. J., Chopra, N. G., Scherer, P. E., Pestell, R. G., & Lisanti, M. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409214200 · Cited by 280
Self-citationRegulation of raft‐dependent endocytosis
Lajoie, P., & Nabi, I. R. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00083.x · Cited by 279
Frick, M., Bright, N. A., Riento, K., Bray, A., Merrified, C., & Nichols, B. J. (2007) · Current Biology · doi:10.1016/j.cub.2007.05.078 · Cited by 279
Zhao, Y.-Y., Zhao, Y. D., Mirza, M. K., Huang, J. H., Potula, H.-H. S. K., Vogel, S. M., Brovkovych, V., Yuan, J. X.-J., Wharton, J., & Malik, A. B. (2009) · Journal of Clinical Investigation · doi:10.1172/jci33338 · Cited by 275
Labrecque, L., Royal, I., Surprenant, D. S., Patterson, C., Gingras, D., & Béliveau, R. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-07-0379 · Cited by 275
Liu, L., & Pilch, P. F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707890200 · Cited by 274
Davis, M. J., Earley, S., Li, Y.-S., & Chien, S. (2023) · Physiological Reviews · doi:10.1152/physrev.00053.2021 · Cited by 273
Growth factor receptors, lipid rafts and caveolae: An evolving story
Pike, L. J. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.05.005 · Cited by 269
Lipid droplet-organelle interactions; sharing the fats
Murphy, S., Martin, S., & Parton, R. G. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.07.004 · Cited by 268
Caveolae: mining little caves for new cancer targets
Carver, L. A., & Schnitzer, J. E. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1146 · Cited by 267
Cholesterol and prostate cancer
Freeman, M. R., & Solomon, K. R. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10724 · Cited by 266
Ramirez, M. I., Millien, G., Hinds, A., Cao, Y., Seldin, D. C., & Williams, M. C. (2003) · Developmental Biology · doi:10.1016/s0012-1606(02)00098-2 · Cited by 264
Fiucci, G., Ravid, D., Reich, R., & Liscovitch, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205300 · Cited by 262
A distinct class of endosome mediates clathrin-independent endocytosis to the Golgi complex
Nichols, B. J. (2002) · Nature Cell Biology · doi:10.1038/ncb787 · Cited by 258
Stan, R. V. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.08.008 · Cited by 258
SDPR induces membrane curvature and functions in the formation of caveolae
Hansen, C. G., Bright, N. A., Howard, G., & Nichols, B. J. (2009) · Nature Cell Biology · doi:10.1038/ncb1887 · Cited by 257
Chung, J.-J., Shim, S.-H., Everley, R. A., Gygi, S. P., Zhuang, X., & Clapham, D. E. (2014) · Cell · doi:10.1016/j.cell.2014.02.056 · Cited by 257
The Biology of Caveolae: Lessons from Caveolin Knockout Mice and Implications for Human Disease
Hnasko, R. (2003) · Molecular Interventions · doi:10.1124/mi.3.8.445 · Cited by 253
Metadata
- Authors
- Razani, B., Engelman, J. A., Wang, X. B., Schubert, W., Zhang, X. L., Marks, C. B., Macaluso, F., Russell, R. G., Li, M., Pestell, R. G., Di Vizio, D., Hou, H., Kneitz, B., Lagaud, G., Christ, G. J., Edelmann, W., & Lisanti, M. P.
- Venue
- Journal of Biological Chemistry
- Published
- 2001-10
- Volume
- 276
- Issue
- 41
- Pages
- 38121-38138
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1643087207
- Cited by
- 1,158
- References
- 96
- FWCI
- 20.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 6940 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.